PNPLA2 and neutral lipid storage myopathy: In humans, PNPLA2 gene bi-allelic loss-of-function mutations also cause extensive LDs accumulation in several organs leading to a disorder named “neutral lipid storage disease with myopathy” (NLSDM), characterised by progressive myopathy, cardiomyopathy and hepatomegaly16,17.